TCL Archive AACR, ASCO Members Concerned Over Ethics, Social Issues, And What To Do About Them May 16, 1975
TCL Archive Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies November 28, 2014
TCL Archive Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing November 1, 2012
TCL Archive New Chemoprevention Program Will Get “Whatever Money It Need;” Clinical Trials In New Division July 25, 1980
